MSK Awards & Appointments June 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Related Articles
| Memorial Sloan Kettering Cancer Center
The Rockefeller Outpatient Pavilion at 53rd Street is temporarily closed following an isolated fire in a non-clinical area on Sunday evening. The fire was quickly…
MSK Research Highlights July 17, 2023
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a…
July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic…
July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic…
When a cancer drug trial has a 100% success rate, you want to know who’s behind it. (It’s Luis Diaz Jr.)
Oncologist Luis Diaz Jr., at Memorial Sloan Kettering, achieved a breakthrough in cancer treatment. He focused on tumors with MMR deficiency.
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from…
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results – Nature Medicine
Prophylactic subcutaneous administration of anakinra, an IL-1 receptor inhibitor, reduced severe immune effector cell-associated neurotoxicity syndrome incidence in patients with relapsed or refractory large B-cell…
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from…
Summer Pipeline Program
This eight-week research program offers students from underrepresented groups in medicine the opportunity to gain research experience under the mentorship of MSK faculty.
Tumor Metabolism Atlas Offers a New Way to Discover Cancer Mechanisms
An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep…